AUSTIN, Texas--(BUSINESS WIRE)--For over 20 years, CEDRA Corporation, a division of Worldwide Clinical Trials, has been an industry leader in providing Bioanalytical Sciences and Phase I-IIb Clinical Research Services. Operating as a division of Worldwide Clinical Trials over the past three years, today, CEDRA Corporation announces its new company name, Worldwide Clinical Trials Drug Development Solutions. This unified name adds to the continuity and full-service offerings our companies collectively provide.
